MedTrace Logo

Triple-arm pH Comparison

NCT02896777 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2273

Last updated 2023-08-21

No results posted yet for this study

Summary

The culturing human embryo in vitro is a process of myriad contributing elements. From these factors is the pH of embryo culture media, which is crucial for embryo development. The investigators plan to examine three different pH values of the culture media on the live birth rate of in vitro cultured human embryos.

Conditions

  • In Vitro Fertilisation Outcome

Interventions

OTHER

Transfer embryo from pH 7.20±0.02 on either Day 3 or day 5/6

Post IVF/ICSI and according to the result of the randomization process, women will receive embryo from their oocytes that will be cultured in pH of 7.20±0.02.

OTHER

Transfer embryo from pH 7.3±0.02 either Day 3 or day 5/6

Post IVF/ICSI and according to the result of the randomization process, women will receive embryo from their oocytes that will be cultured in pH of 7.3±0.02.

OTHER

Transfer embryo from pH of 7.4±0.02 on either Day 3 or day 5/6

Post IVF/ICSI and according to the result of the randomization process, women will receive embryo from their oocytes that will be cultured in pH of 7.4±0.02 from day 0 to 5/6

Sponsors & Collaborators

  • Egyptian IVF Center

    collaborator OTHER

  • Banon IVF Center Assiut, Egypt

    collaborator OTHER

  • Ibn Sina Hospital

    lead OTHER_GOV

Principal Investigators

  • Mohamed Fawzy · Ibnsina Hospital

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-13
Primary Completion
2023-04-27
Completion
2023-08-11

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02896777 on ClinicalTrials.gov